181 related articles for article (PubMed ID: 25692307)
21. Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis.
Kaptein JS; Lin CK; Wang CL; Nguyen TT; Kalunta CI; Park E; Chen FS; Lad PM
J Biol Chem; 1996 Aug; 271(31):18875-84. PubMed ID: 8702548
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
Smith-Sørensen B; Hijmans EM; Beijersbergen RL; Bernards R
J Biol Chem; 1996 Mar; 271(10):5513-8. PubMed ID: 8621409
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
26. Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin.
Alfhili MA; Alsalmi E; Aljedai A; Alsughayyir J; Abudawood M; Basudan AM
J Chemother; 2022 Jul; 34(4):247-257. PubMed ID: 34410893
[TBL] [Abstract][Full Text] [Related]
27. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS
Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
29. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.
Challagundla KB; Sun XX; Zhang X; DeVine T; Zhang Q; Sears RC; Dai MS
Mol Cell Biol; 2011 Oct; 31(19):4007-21. PubMed ID: 21807902
[TBL] [Abstract][Full Text] [Related]
30. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.
Klefstrom J; Arighi E; Littlewood T; Jäättelä M; Saksela E; Evan GI; Alitalo K
EMBO J; 1997 Dec; 16(24):7382-92. PubMed ID: 9405367
[TBL] [Abstract][Full Text] [Related]
31. Expression of c-fos and c-myc in Raji Burkitt's lymphoma cells during the progression of DMSO-induced G1 cells into S phase.
Teraoka H; Sawai M; Takase K; Yamamoto K; Nozaki N; Okazaki T; Tsukada K
Exp Cell Res; 1991 Jul; 195(1):274-6. PubMed ID: 1905238
[TBL] [Abstract][Full Text] [Related]
32. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
33. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.
Molina-Privado I; Rodríguez-Martínez M; Rebollo P; Martín-Pérez D; Artiga MJ; Menárguez J; Flemington EK; Piris MA; Campanero MR
Cancer Res; 2009 May; 69(9):4052-8. PubMed ID: 19406837
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
[TBL] [Abstract][Full Text] [Related]
35. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
[TBL] [Abstract][Full Text] [Related]
36. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
[TBL] [Abstract][Full Text] [Related]
37. Gene-hypermutated isoforms of MYC protein: Tumour-suppressor P-53 protective-initiation of apoptosis that normally prevents Burkitt's lymphoma tumorigenesis can be enhanced.
Wiseman A
Med Hypotheses; 2006; 66(5):1046-7. PubMed ID: 16413684
[No Abstract] [Full Text] [Related]
38. MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.
Li Y; Challagundla KB; Sun XX; Zhang Q; Dai MS
Oncotarget; 2015 Jan; 6(2):1101-14. PubMed ID: 25544755
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
40. p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.
Jung JH; Lee H; Kim JH; Sim DY; Ahn H; Kim B; Chang S; Kim SH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31022952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
